Prosecution Insights
Last updated: April 19, 2026
Application No. 18/325,470

DISHWASHING DETERGENT COMPOSITION COMPRISING XYLANASE AND BLOCK CO-POLYMER

Non-Final OA §102§103§112§DP
Filed
May 30, 2023
Examiner
FAN, LYNN Y
Art Unit
1759
Tech Center
1700 — Chemical & Materials Engineering
Assignee
The Procter & Gamble Company
OA Round
1 (Non-Final)
47%
Grant Probability
Moderate
1-2
OA Rounds
3y 9m
To Grant
96%
With Interview

Examiner Intelligence

Grants 47% of resolved cases
47%
Career Allow Rate
221 granted / 472 resolved
-18.2% vs TC avg
Strong +49% interview lift
Without
With
+48.7%
Interview Lift
resolved cases with interview
Typical timeline
3y 9m
Avg Prosecution
50 currently pending
Career history
522
Total Applications
across all art units

Statute-Specific Performance

§101
4.5%
-35.5% vs TC avg
§103
45.5%
+5.5% vs TC avg
§102
11.2%
-28.8% vs TC avg
§112
25.2%
-14.8% vs TC avg
Black line = Tech Center average estimate • Based on career data from 472 resolved cases

Office Action

§102 §103 §112 §DP
DETAILED ACTION The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Status of the Claims Claims 10-15 have been added. Claims 1-15 are currently pending. Election/Restrictions Applicant’s election without traverse of species EOx1POy1EOx2, sulphonated acrylic polymer, and glycosyl hydrolases from GH family 11, in the reply filed on 12/29/2025 is acknowledged. Claims 6-7, 12-13 and 15 have been withdrawn from further consideration pursuant to 37 CFR 1.142(b), as being drawn to nonelected inventions and species, there being no allowable generic or linking claims. Claims 1-5, 8-11 and 14 are being examined in this application, insofar as they read on the elected species of EOx1POy1EOx2, sulphonated acrylic polymer, and glycosyl hydrolases from GH family 11. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-5, 8-11 and 14 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor, or for pre-AIA the applicant regards as the invention. Claims 1 (line 2) and 2 (line 5-6), the recitation of “about” is indefinite. The instant specification does not provide a definition of the term “about”, and it is unclear as to what range of specific cloud point (in claim 1) and ethylene / propylene oxide unit (in claim 2) is covered by the term “about”. (MPEP 2173.05(b) III) Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale or otherwise available to the public before the effective filing date of the claimed invention. (a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. Claims 1-5, 8-9 and 14 are rejected under 35 U.S.C. 102(a)(1)/(2) as being anticipated by Denome et al (US 2018/0216050 A1; 8/2/2018.) as evidenced by BASF (BASF TI/ES 1026 e. 2005;1-16.) and Bodratti et al (J. Funct. Biomater. 2018;9(11):1-24.). The instant claims recite a dishwashing detergent composition comprising a xylanase and an ethylene oxide - propylene oxide block copolymer having a cloud point of about 20°C or greater than about 20°C. Denome teaches a composition comprising xylanases (para 0114) and an ethylene oxide-propylene oxide-ethylene oxide (EOx1POyEOx2) triblock copolymer (para 0051), wherein each ethylene oxide block or chain independently has an average chain length of between 3 and 50 ethylene oxide units (para 0053), an average propylene oxide chain length of between 20 and 70 propylene oxide units (para 0051), and suitable ethylene oxide-propylene oxide-ethylene oxide triblock copolymers include Pluronic PE 9200 (para 0057), which has a cloud point of about 20°C or greater than about 20°C as evidenced by BASF (p.5 Table) and a structure of EO8PO47EO8 as evidenced by Bodratti (p.8 Figure 4). The composition further comprises a sulfonated acrylic acid copolymer (para 0118). The recommended dosage for a unit dose product is placed in a pouch (para 0237). The composition further comprises a bleach catalyst (para 0110, 0138). The composition further comprises a chelant (para 0068). The limitation of “dishwashing detergent” is regarded as an intended use limitation. The claiming of a new use, function or unknown property does not necessarily make the composition patentable. The intended use of the claimed composition does not patentably distinguish the composition, per se, since such undisclosed use is inherent in the reference composition. In order to be limiting, the intended use must create a structural difference between the claimed composition and the composition of the prior art. In the instant case, the intended use fails to create a structural difference, thus, the intended use is not limiting. Please note that when applicant claims a composition in terms of function, and the composition of the prior art appears to be the same, the Examiner may make rejections under both 35 U.S.C 102 and 103. (MPEP 2112) Therefore the reference anticipates the claimed subject matter. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102 of this title, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim 10 is rejected under 35 U.S.C. 103 as being unpatentable over Denome et al (US 2018/0216050 A1; 8/2/2018.) as evidenced by BASF (BASF TI/ES 1026 e. 2005;1-16.) and Bodratti et al (J. Funct. Biomater. 2018;9(11):1-24.) as applied to claims 1-5, 8-9 and 14 above, further in view of Lant et al (US 8,349,789 B2; 1/8/2013.). Denome does not teach the bleach catalyst comprises a manganese or cobalt-containing bleach catalyst (claim 10). However, Denome does teach the composition comprises a bleach catalyst, and the composition is placed into a washing machine along with the laundry to be washed, and carrying out a washing or cleaning operation (para 0008). Lant teaches a laundry composition (Title) comprising bleach catalysts (col.4 line 11), wherein if desired, the composition can be catalyzed by means of a manganese compound, such compounds and levels of use are well known in the art (col.13 line 1-3), useful cobalt bleach catalysts are known in the art, and readily prepared by known procedures (col.13 line 6-9). Thus, before the effective filing date of the claimed invention, it would have been obvious to one of ordinary skill in the art to incorporate a manganese or cobalt-containing bleach catalyst, since Denome and Lant both disclose a household care composition comprises bleach catalysts, and Lant discloses that a manganese or cobalt-containing bleach catalyst are well known and routinely used within a household care composition. Moreover, before the effective filing date of the claimed invention, one of ordinary skill in the art would have been motivated by the cited reference and routine practice to incorporate a manganese or cobalt-containing bleach catalyst, with a reasonable expectation for successfully obtaining a composition. Claim 11 is rejected under 35 U.S.C. 103 as being unpatentable over Denome et al (US 2018/0216050 A1; 8/2/2018.) as evidenced by BASF (BASF TI/ES 1026 e. 2005;1-16.) and Bodratti et al (J. Funct. Biomater. 2018;9(11):1-24.) as applied to claims 1-5, 8-9 and 14 above, further in view of Collins et al (FEMS Microbiology Reviews. 2005;29:3-23.). Denome does not teach the xylanase is from GH family 11 (claim 11). However, Denome does teach the composition comprises xylanases. Collins teaches GH family 11 is monospecific and consists solely of xylanases, these xylanases are “true xylanases” (p.10 col right – para 3), and family 11 has more members with a demonstrated activity on xylan (p.6 Table 1). Thus, before the effective filing date of the claimed invention, it would have been obvious to one of ordinary skill in the art to incorporate xylanase from GH family 11, since Denome discloses a composition comprises xylanases, and Collins discloses that xylanases from GH family 11 are the most typical and true xylanases known to have higher specific activity for xylans. Moreover, before the effective filing date of the claimed invention, one of ordinary skill in the art would have been motivated by the cited reference and routine practice to incorporate xylanase from GH family 11, with a reasonable expectation for successfully obtaining a composition. Double Patenting The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the claims at issue are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); and In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969). A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on a nonstatutory double patenting ground provided the reference application or patent either is shown to be commonly owned with this application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b). The USPTO internet Web site contains terminal disclaimer forms which may be used. Please visit http://www.uspto.gov/forms/. The filing date of the application will determine what form should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to http://www.uspto.gov/patents/process/file/efs/guidance/eTD-info-I.jsp. Claims 1-5, 8-11 and 14 are provisionally rejected on the ground of nonstatutory obviousness-type double patenting as being unpatentable over claims 1-5 and 7-9 of co-pending Application No. 18/325,455 (referred to as the ‘455 application) in view of Denome et al (US 2018/0216050 A1; 8/2/2018.) and Lant et al (US 8,349,789 B2; 1/8/2013.). Claims 1-5 and 7-9 of the ‘455 application recites a dishwashing detergent composition comprising a xylanase and a sulphonated carboxylate polymer, wherein the xylanase is from GH family 11. The composition further comprises an ethylene oxide - propylene oxide block copolymer having a cloud point of about 20°C or greater than about 20°C, wherein the block copolymer has structure of EOx1POy1EOx2. The composition is in the form of a unit dose pouch. The composition further comprises a bleach catalyst and a chelant. ‘455 application does not teach the sulphonated carboxylate polymer comprises a sulphonated acrylic polymer (claim 4). However, ‘455 application does teach the dishwashing detergent composition comprises a xylanase and a sulphonated carboxylate polymer. Denome teaches a composition comprising xylanases (para 0114) and sulfonated acrylic acid copolymer (para 0118). Thus, before the effective filing date of the claimed invention, it would have been obvious to one of ordinary skill in the art to incorporate a sulphonated acrylic polymer, since ‘455 application and Denome both disclose a household care composition comprises sulphonated carboxylate polymer, and Denome discloses that a sulphonated acrylic polymer is used as a dispersing agent. Moreover, before the effective filing date of the claimed invention, one of ordinary skill in the art would have been motivated by the cited reference and routine practice to incorporate a sulphonated acrylic polymer, with a reasonable expectation for successfully obtaining a dishwashing detergent composition. References cited above do not teach the bleach catalyst comprises a manganese or cobalt-containing bleach catalyst (claim 10). However, ‘455 application does teach the dishwashing detergent composition comprises bleach catalysts. Lant teaches a laundry composition (Title) comprising bleach catalysts (col.4 line 11), wherein if desired, the composition can be catalyzed by means of a manganese compound, such compounds and levels of use are well known in the art (col.13 line 1-3), useful cobalt bleach catalysts are known in the art, and readily prepared by known procedures (col.13 line 6-9). Thus, before the effective filing date of the claimed invention, it would have been obvious to one of ordinary skill in the art to incorporate a manganese or cobalt-containing bleach catalyst, since ‘455 application and Lant both disclose a household care composition comprises bleach catalysts, and Lant discloses that a manganese or cobalt-containing bleach catalyst are well known and routinely used within a household care composition. Moreover, before the effective filing date of the claimed invention, one of ordinary skill in the art would have been motivated by the cited reference and routine practice to incorporate a manganese or cobalt-containing bleach catalyst, with a reasonable expectation for successfully obtaining a dishwashing detergent composition. This is a provisional obviousness-type double patenting rejection because the patentably indistinct claims have not in fact been patented. Conclusion No claims are allowed. Contact Information Any inquiry concerning this communication or earlier communications from the examiner should be directed to LYNN Y FAN whose telephone number is (571)270-3541. The examiner can normally be reached on M-F 7am-4pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Curtis Mayes can be reached on (571)272-1234. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /Lynn Y Fan/ Primary Examiner, Art Unit 1759
Read full office action

Prosecution Timeline

May 30, 2023
Application Filed
Mar 13, 2026
Non-Final Rejection — §102, §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12578336
ATP DETECTION
2y 5m to grant Granted Mar 17, 2026
Patent 12570924
CONTACT LENS CLEANING AGENT
2y 5m to grant Granted Mar 10, 2026
Patent 12564202
COMPOSITION FOR ALLEVIATING, PREVENTING OR TREATING SARCOPENIA, CONTAINING WHEY PROTEIN HYDROLYSATE AS ACTIVE INGREDIENT
2y 5m to grant Granted Mar 03, 2026
Patent 12558386
METHODS AND COMPOSITIONS TO MODULATE ANTIBIOTIC RESISTANCE AND GASTROINTESTINAL MICROBIOTA
2y 5m to grant Granted Feb 24, 2026
Patent 12550887
PERFUSION SOLUTION
2y 5m to grant Granted Feb 17, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
47%
Grant Probability
96%
With Interview (+48.7%)
3y 9m
Median Time to Grant
Low
PTA Risk
Based on 472 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month